Barbara Vergani

Sulfinimines of trifluoropyruvate: Novel intermediates for chiral non racemic α-trifluoromethyl α-amino acids

Pierfrancesco Bravo, Marcello Crucianelli, Barbara Vergani et al. · Tetrahedron Letters · 1998 · 65 citations

Natural Sciences, Biochemistry, Chemistry +8

Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation

Barbara Vergani, Giovanni Sandrone, Mattia Marchini et al. · Journal of Medicinal Chemistry · 2019 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19

Chiara Ripamonti, Valeria Spadotto, Pietro Pozzi et al. · Frontiers in Immunology · 2022 · 43 citations · Full text

Life Sciences, Immunology, Pharmacology +13

Experimental Evidence for Intramolecular Attractive Nonbonded C–F…H–C Interactions in 2′,3′-Dideoxy-4′-(fluoromethyl)nucleosides – Through-SpaceJCF andJHF NMR Coupling Constants, Correlation with Empirical Parameters of Solvent Polarity and Single-Crystal X-ray Structures

Andrea Mele, Barbara Vergani, Fiorenza Viani et al. · European Journal of Organic Chemistry · 1999 · 39 citations

Life Sciences, Biochemistry, Chemistry +14

Difluoromethyl-1,3,4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity

Edoardo Cellupica, Gianluca Caprini, Paola Cordella et al. · Journal of Biological Chemistry · 2022 · 39 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6